Navigation Links
New Class of Drugs May Fight Alzheimer's
Date:6/11/2008

Cousin of some NSAIDS, it could prevent buildup of plaque in the brain, study says

WEDNESDAY, June 11 (HealthDay News) -- A class of drugs called gamma-secretase modulators shows potential for treating Alzheimer's disease, a new study suggests.

A hallmark of Alzheimer's is so-called amyloid plaque, which develops tangles in the brain. The gamma-secretase modulators reduce the production of long pieces of amyloid beta protein that stick together and form clumps. At the same time, the drugs increase the production of shorter amyloid beta that blocks longer amyloid beta from sticking together, the researchers explained.

"We have discovered a novel mechanism of action for a class of drugs that are currently being tested as Alzheimer's disease therapeutics," said lead researcher Dr. Todd E. Golde, an associate professor at the Mayo Clinic Department of Neuroscience, in Jacksonville, Fla.

These new drugs don't work in the same way that many other drugs do, Golde said. "Sometimes we think of drugs as magic bullets targeting a single entity, but this drug, by the way it works, could have three consequences that could have a benefit for Alzheimer's disease," he said.

While the new compounds decrease the production of long chains of amyloid beta, Golde said, "Surprisingly, they increase the presence of shorter chains of amyloid beta, which we think actually prevents the accumulation of longer chains of amyloid beta."

"In a short form, amyloid beta is harmless as far as we know," he added. "So you sort of get three bangs for your buck."

"This finding could tell us how drugs for Alzheimer's disease already in clinical trials may be working," Golde said. One of the modulator drugs, tarenflurbil (Flurizan), was in a just-completed phase III clinical trial, and the results should be available this summer, he said.

The latest findings are published in the June 12 edition of Nature.

One expert thinks the new research could produce a drug that could fight the development of amyloid plaque in two ways.

"This is interesting and unexpected," said Dr. Sam Gandy, chairman of the Alzheimer's Association's National Medical and Scientific Advisory Council. "This suggests that it might be possible to design or identify compounds that both modulate generation of amyloid beta and at the same time modulate accumulation of amyloid beta."

Until now, anti-amyloid drugs have fallen into three broad classes: immunotherapies, anti-aggregation compounds, and secretase modulators, Gandy said. "The new work suggests that there exist single drugs that possess both of the latter two activities, thereby supplying an anti-amyloid double whammy," he said.

Another expert thinks this avenue of attack on amyloid plaque looks promising.

"Chronic intake of NSAIDs like ibuprofen appears to reduce the risk of Alzheimer's," said Greg M. Cole, associate director of the Alzheimer's Disease Research Center at UCLA David Geffen School of Medicine.

"A subset of NSAIDs that the authors call gamma-secretase modulators appears to reduce the accumulation of the stickiest form of beta amyloid protein that is believed to aggregate and cause the disease," Cole said. "This means that the known protective NSAIDs may be a double threat against Alzheimer's and help protect against it if they are taken early for prevention."

More information

For more on Alzheimer's disease, visit the Alzheimer's Association.



SOURCES: Todd E. Golde M.D., Ph.D., associate professor, Department of Neuroscience, Mayo Clinic, Jacksonville, Fla.; Sam Gandy, M.D., chairman, Alzheimer's Association National Medical and Scientific Advisory Council, Chicago; Greg M. Cole, Ph.D., neuroscientist, Greater Los Angeles VA Healthcare System, and associate director, Alzheimer's Disease Research Center, UCLA David Geffen School of Medicine; June 12, 2008, Nature


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
2. ADDA Kicks Off AD/HD Awareness Campaign with Four Regional Conferences Beginning Sept. 29 and Series of Fall Teleclasses
3. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
4. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
5. Theater Classes Help Docs Bedside Manners
6. Tarpinian: Misclassification is Theft
7. New class of RNA molecules may be important in human cancer
8. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
9. Consumer Group: Hillary Clintons Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Cant Afford $12k Policy
10. SATELLITE BROADCAST: Consumer Group Says Hillary Clintons Mandatory Health Insurance Plan is an Act of War on the Middle Class that Cant Afford $12k Policy
11. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Class of Drugs May Fight Alzheimer's
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
Breaking Medicine Technology: